AA
CMRAW

AQR Arbitrage’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

AQR Arbitrage’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-52,222
Closed -$7K – 1509
2022
Q2 		$7K Buy
+52,222
New +$8.55K ﹤0.01% 1296

Other funds holding CMRAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return

AQR Arbitrage's CMRAW Position: Q3 2022 in Review

AQR Arbitrage sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q3 2022, closing a stake of 52,222 shares — an estimated $7K sold.

AQR Arbitrage first reported a position in CMRAW in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 19 funds tracked by Wall St. Rank hold CMRAW as of Q3 2022.

  • AQR Arbitrage reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q3 2022 after selling out during the quarter.
  • AQR Arbitrage sold 52,222 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q3 2022, an estimated $7K.
  • AQR Arbitrage first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 1 quarter.
  • AQR Arbitrage's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $7K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q3 2022.

Based on AQR Arbitrage's 13F filing for Q3 2022, filed 14 Nov 2022.